Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||
| Net Income | -3,662 | -780 | 60 |
| Depreciation Amortization | 190 | 96 | 380 |
| Accounts receivable | 69 | 480 | N/A |
| Accounts payable and accrued liabilities | 488 | 370 | N/A |
| Other Working Capital | -117 | 184 | -3,940 |
| Other Operating Activity | -374 | -768 | 430 |
| Operating Cash Flow | $-3,407 | $-419 | $-3,070 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -5 | -2 | -40 |
| Investing Cash Flow | $-5 | $-2 | $-40 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 1,362 | N/A | N/A |
| Debt Repayment | -137 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 320 |
| Financing Cash Flow | $1,225 | $N/A | $320 |
| Exchange Rate Effect | -17 | 1 | 160 |
| Beginning Cash Position | 3,689 | 3,689 | 6,320 |
| End Cash Position | 1,485 | 3,270 | 3,680 |
| Net Cash Flow | $-2,204 | $-420 | $-2,630 |
| Free Cash Flow | |||
| Operating Cash Flow | -3,407 | -419 | -3,070 |
| Capital Expenditure | -5 | -2 | N/A |
| Free Cash Flow | -3,412 | -420 | -3,070 |